Literature DB >> 19219463

Minimal change disease with IgM+ immunofluorescence: a subtype of nephrotic syndrome.

Sarah J Swartz1, Karen W Eldin, M John Hicks, Daniel I Feig.   

Abstract

Immunoglobulin (Ig) M nephropathy is defined by electron-dense mesangial deposits and mesangial IgM visible by immunofluorescence (IF) without other histopathologic and immunofluorescent microscopic abnormalities. Certain patients have only immuno-positive (IgM+) IF. Children presenting with steroid-dependent or steroid-resistant nephrotic syndrome have a high prevalence of IgM+ IF with or without electron-dense deposits. We reviewed the clinical course of children with steroid-dependent or steroid-resistant nephrotic syndrome who underwent renal biopsy at Texas Children's Hospital from 1989 to 2006 to further characterize IgM+ IF in children with nephrotic syndrome. Of the 55 children with steroid-resistant or -dependent minimal change disease (MCD), 23 had IgM+ IF. Of these 23 children, 61% had microscopic hematuria at presentation, 48% (11/23) were steroid-dependent, and 48% (11/23) steroid-resistant (one underwent biopsy prior to steroid therapy). We compared the efficacy of adjuvant treatment with cyclophosphamide and cyclosporine: 18% initially treated with cyclophosphamide obtained remission, while 55% had no response; 83% obtained subsequent remission with cyclosporine. Of those initially treated with cyclosporine, 88% obtained complete or partial remission. IgM+ IF may be surrogate marker for the severity of MCD. Based on our results, children with MCD and IgM+ IF have a better response to cyclosporine than cyclophosphamide.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19219463     DOI: 10.1007/s00467-009-1130-0

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  36 in total

1.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.

Authors: 
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

2.  Long-term cyclosporine therapy for pediatric nephrotic syndrome: a clinical and histologic analysis.

Authors:  M J Gregory; W E Smoyer; A Sedman; D B Kershaw; R P Valentini; K Johnson; T E Bunchman
Journal:  J Am Soc Nephrol       Date:  1996-04       Impact factor: 10.121

3.  Long-term follow-up in children with steroid-resistant nephrotic syndrome.

Authors:  N Besbas; R Topaloglu; O Saatci; A Bakkaloglu
Journal:  Clin Pediatr (Phila)       Date:  1992-05       Impact factor: 1.168

Review 4.  Mesangial IgM nephropathy.

Authors:  A Tejani; A D Nicastri
Journal:  Nephron       Date:  1983       Impact factor: 2.847

5.  No evidence for a specific role of IgM in mesangial proliferation of idiopathic nephrotic syndrome.

Authors:  Y Ji-Yun; T Melvin; R Sibley; A F Michael
Journal:  Kidney Int       Date:  1984-01       Impact factor: 10.612

6.  Primary focal segmental glomerulosclerosis in children: prognostic factors.

Authors:  R Martinelli; A S Okumura; L J Pereira; H Rocha
Journal:  Pediatr Nephrol       Date:  2001-08       Impact factor: 3.714

7.  Steroid-dependent nephrotic syndrome in children: histopathology and relapses after cyclophosphamide treatment.

Authors:  N J Siegel; K M Gaudio; L S Krassner; B M McDonald; F P Anderson; M Kashgarian
Journal:  Kidney Int       Date:  1981-03       Impact factor: 10.612

8.  Mesangial proliferative glomerulonephritis.

Authors:  H K Bhasin; J G Abuelo; R Nayak; A R Esparza
Journal:  Lab Invest       Date:  1978-07       Impact factor: 5.662

9.  IgM-associated glomerulonephritis.

Authors:  H Helin; J Mustonen; A Pasternack; J Antonen
Journal:  Nephron       Date:  1982       Impact factor: 2.847

10.  The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children.

Authors: 
Journal:  J Pediatr       Date:  1981-04       Impact factor: 4.406

View more
  17 in total

1.  Is cyclophosphamide effective in patients with IgM-positive minimal change disease?

Authors:  Pavel Geier; Amani Roushdi; Sylva Skálová; Jennifer Vethamuthu; Gabrielle Weiler; Janusz Feber
Journal:  Pediatr Nephrol       Date:  2012-06-24       Impact factor: 3.714

2.  IgM nephropathy in India: a single centre experience.

Authors:  Aruna V Vanikar; Kamal V Kanodia; Rashmi D Patel; Kamlesh S Suthar; Himanshu V Patel; Manoj R Gumber; Hargovind L Trivedi
Journal:  Indian J Pediatr       Date:  2012-08       Impact factor: 1.967

3.  Do C1q or IgM nephropathies predict disease severity in children with minimal change nephrotic syndrome?

Authors:  Mateja Vintar Spreitzer; Alenka Vizjak; Dušan Ferluga; Rajko B Kenda; Tanja Kersnik Levart
Journal:  Pediatr Nephrol       Date:  2013-07-13       Impact factor: 3.714

Review 4.  IgM nephropathy; can we still ignore it.

Authors:  Aruna Vanikar
Journal:  J Nephropathol       Date:  2013-04-01

Review 5.  IgM nephropathy: is it closer to minimal change disease or to focal segmental glomerulosclerosis?

Authors:  R Brugnano; R Del Sordo; C Covarelli; E Gnappi; S Pasquali
Journal:  J Nephrol       Date:  2016-02-03       Impact factor: 3.902

6.  Mycophenolate mofetil (MMF) treatment efficacy in children with primary and secondary glomerulonephritis.

Authors:  Danuta Ostalska-Nowicka; Agnieszka Malinska; Magdalena Silska; Bartlomiej Perek; Jacek Zachwieja; Michal Nowicki
Journal:  Arch Med Sci       Date:  2011-12-30       Impact factor: 3.318

7.  IgM exacerbates glomerular disease progression in complement-induced glomerulopathy.

Authors:  Sarah E Panzer; Jennifer Laskowski; Brandon Renner; Liudmila Kulik; Danica Ljubanovic; Kendra M Huber; Weixiong Zhong; Matthew C Pickering; V Michael Holers; Joshua M Thurman
Journal:  Kidney Int       Date:  2015-05-06       Impact factor: 10.612

8.  Prevalence of Glomerulopathies in Canine Mammary Carcinoma.

Authors:  Leandro Z Crivellenti; Gyl E B Silva; Sofia Borin-Crivellenti; Rachel Cianciolo; Christopher A Adin; Márcio Dantas; Denner S Dos Anjos; Mirela Tinucci-Costa; Aureo E Santana
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

9.  The natural history of immunoglobulin M nephropathy in adults.

Authors:  Thomas M Connor; Valeria Aiello; Megan Griffith; Thomas Cairns; Candice A Roufosse; H Terence Cook; Charles D Pusey
Journal:  Nephrol Dial Transplant       Date:  2017-05-01       Impact factor: 5.992

10.  Significance of electron dense deposits in patients with minimal change nephrotic syndrome.

Authors:  Sae Yoon Kim; Sang Su Lee; Myoung Uk Kim; Jae Min Lee; Seok Jeong Kang; Yong Jin Kim; Yong Hoon Park
Journal:  Korean J Pathol       Date:  2012-04-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.